SEC Form 4 · accession 0001179110-16-026417
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bobby Dwayne Montgomery
Officer — Chief Executive Officer · Director
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $12.39 | Jun 9, 2016 | D | 6,250 | A | Apr 21, 2017 | Apr 21, 2024 | Common Stock | 6,250 | 41,250 | D |
| Incentive Stock Options (right to buy)F1 | $12.39 | Jun 9, 2016 | D | 6,250 | A | Apr 21, 2018 | Apr 21, 2024 | Common Stock | 6,250 | 35,000 | D |
| Incentive Stock Options (right to buy)F1 | $18.40 | Jun 9, 2016 | D | 3,125 | A | Mar 6, 2017 | Mar 6, 2025 | Common Stock | 3,125 | 31,875 | D |
| Incentive Stock Option (right to buy)F1 | $18.40 | Jun 9, 2016 | D | 3,125 | A | Mar 6, 2018 | Mar 6, 2025 | Common Stock | 3,125 | 28,750 | D |
| Incentive Stock Option (right to buy)F1 | $18.40 | Jun 9, 2016 | D | 3,125 | A | Mar 6, 2019 | Mar 6, 2025 | Common Stock | 3,125 | 25,625 | D |
| Incentive Stock Option (right to buy)F1 | $7.39 | Jun 9, 2016 | D | 2,500 | A | Mar 4, 2017 | Mar 4, 2026 | Common Stock | 2,500 | 23,125 | D |
| Incentive Stock Option (right to buy)F1 | $7.39 | Jun 9, 2016 | D | 2,500 | A | Mar 4, 2018 | Mar 4, 2026 | Common Stock | 2,500 | 20,625 | D |
| Incentive Stock Option (right to buy)F1 | $7.39 | Jun 9, 2016 | D | 2,500 | A | Mar 4, 2019 | Mar 4, 2026 | Common Stock | 2,500 | 18,125 | D |
| Incentive Stock Option (right to buy)F1 | $7.39 | Jun 9, 2016 | D | 2,500 | A | Mar 4, 2020 | Mar 4, 2026 | Common Stock | 2,500 | 15,625 | D |
Explanation of responses
- F1Unvested incentive stock options that were forfeited concurrent with the Reporting Person's separation from the company, consistent with the provisions of the Amended and Restated 2006 Omnibus Plan. The Reporting Person's stock options that were vested on the date that he separated from the company will remain exercisable for 90 days from the departure date.